GSS genetic signatures limited

Ann: Investor webinar presentation, page-4

  1. 467 Posts.
    lightbulb Created with Sketch. 76
    There was already 4 Mill in rev for next quarter last quarter (30 day order payments) and Covid testing has not stopped since then. And also the vibe is once COVID goes away that they will not have revenue...but ummm...do you see COVID going away anytime soon. Lets say even we get things under control, testing is going to be prevalent so we KEEP things under control, and by then they should have made some headway with the FDA approval.

    There seems to be some sort of relentless selling, but all indicators look like a buy in my opinion.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
39.0¢
Change
-0.010(2.50%)
Mkt cap ! $88.58M
Open High Low Value Volume
40.0¢ 40.0¢ 39.0¢ $15.24K 38.66K

Buyers (Bids)

No. Vol. Price($)
1 2000 38.5¢
 

Sellers (Offers)

Price($) Vol. No.
40.0¢ 9500 2
View Market Depth
Last trade - 10.17am 23/07/2025 (20 minute delay) ?
GSS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.